Abstract
Obsessive-compulsive disorder (OCD) is characterised by structural and functional deficits in the cortico-striato-thalamic-cortical (CSTC) circuitry and abnormal neurochemical changes are thought to modulate these deficits. The hypothesis that an imbalanced concentration of the brain neurotransmitters, in particular glutamate (Glu) and gamma-amino-butyric acid (GABA), could impair the normal functioning of the CSTC, thus leading to OCD symptoms, has been tested in humans using magnetic resonance spectroscopy (MRS) and positron emission tomography (PET). This chapter summarises these neurochemical findings and represents an attempt to condense such scattered literature. We also discuss potential challenges in the field that may explain the inconsistent findings and suggest ways to overcome them. There is some convergent research from MRS pointing towards abnormalities in the brain concentration of neurometabolite markers of neuronal integrity, such as N-acetylaspartate (NAA) and choline (Cho). Lower NAA levels have been found in dorsal and rostral ACC of OCD patients (as compared to healthy volunteers), which increase after CBT and SSRI treatment, and higher Cho concentration has been reported in the thalamus of the OCD brain. However, findings for other neurometabolites are very inconsistent. Studies have reported abnormalities in the concentrations of creatine (Cr), GABA, glutamate (Glu), glutamine (Gln), Ins (myo-inositol), and serotonin (5-HT), but most of the results were not replicated. The question remains whether the NAA and Cho findings are genuinely the only neurochemical abnormalities in OCD or whether the lack of consistent findings for the other neurometabolites is caused by the lower magnetic field (1–3 Tesla (T)) used by the studies conducted so far, their small sample sizes or a lack of proper control for medication effects. To answer these questions and to further inform the biological underpinning of the symptoms and the cognitive problems at the basis of OCD we need better controlled studies using clear medicated vs unmedicated groups, larger sample sizes, stronger magnetic fields (e.g. at 7 T), and more consistency in the definition of the regions of interest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S et al (2005) Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8(3):391–401. https://doi.org/10.1017/s1461145705005055
Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C et al (2014) Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 17(12):1915–1922. https://doi.org/10.1017/s1461145714000716
Alcaraz F, Fresno V, Marchand AR, Kremer EJ, Coutureau E, Wolff M (2018) Thalamocortical and corticothalamic pathways differentially contribute to goal-directed behaviors in the rat. eLife 7:e32517. https://doi.org/10.7554/eLife.32517
Alger JR (2010) Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review. Top Magn Reson Imaging 21(2):115–128. https://doi.org/10.1097/RMR.0b013e31821e568f
Alvarenga PG, do Rosário MC, Batistuzzo MC, Diniz JB, Shavitt RG, Duran FL et al (2012) Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naïve patients. J Psychiatr Res 46(12):1635–1642. https://doi.org/10.1016/j.jpsychires.2012.09.002
Apergis-Schoute AM, Bijleveld B, Gillan CM, Fineberg NA, Sahakian BJ, Robbins TW (2018) Hyperconnectivity of the ventromedial prefrontal cortex in obsessive-compulsive disorder. Brain Neurosci Adv 2:2398212818808710. https://doi.org/10.1177/2398212818808710
Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E (2009) Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 63(4):486–490. https://doi.org/10.1111/j.1440-1819.2009.01993.x
Bagory M, Durand-Dubief F, Ibarrola D, Confavreux C, Sappey-Marinier D (2007) "Absolute" quantification in magnetic resonance spectroscopy: validation of a clinical protocol in multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc 2007:3458–3461. https://doi.org/10.1109/iembs.2007.4353075
Banca P, Voon V, Vestergaard MD, Philipiak G, Almeida I, Pocinho F et al (2015) Imbalance in habitual versus goal directed neural systems during symptom provocation in obsessive-compulsive disorder. Brain 138(Pt 3):798–811. https://doi.org/10.1093/brain/awu379
Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ et al (1998) A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 155(11):1584–1591. https://doi.org/10.1176/ajp.155.11.1584
Baxter LR (1990) Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. J Clin Psychiatry 51(Suppl):22–25; discussion 26
Bédard MJ, Chantal S (2011) Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression. Psychiatry Res 192(1):45–54. https://doi.org/10.1016/j.pscychresns.2010.10.008
Benazon NR, Moore GJ, Rosenberg DR (2003) Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry 42(11):1279–1285. https://doi.org/10.1097/01.chi.0000087562.01900.de
Boer VO, Klomp DWJ (2014) Chapter 1.3 – technical considerations for multivoxel approaches and magnetic resonance spectroscopic imaging. In: Stagg C, Rothman D (eds) Magnetic resonance spectroscopy. Academic Press, San Diego, pp 31–39
Brennan BP, Rauch SL, Jensen JE, Pope HG Jr (2013) A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry 73(1):24–31. https://doi.org/10.1016/j.biopsych.2012.06.023
Brennan BP, Jensen JE, Perriello C, Pope HG Jr, Jenike MA, Hudson JI et al (2016) Lower posterior cingulate cortex glutathione levels in obsessive-compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 1(2):116–124. https://doi.org/10.1016/j.bpsc.2015.12.003
Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr (1998) FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84(1):1–6. https://doi.org/10.1016/s0925-4927(98)00041-9
Brownell A-L, Jenkins BG, Elmaleh DR, Deacon TW, Spealman RD, Isacson O (1998) Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease. Nat Med 4(11):1308–1312. https://doi.org/10.1038/3300
Celada P, Puig MV, Artigas F (2013) Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 7:25–25. https://doi.org/10.3389/fnint.2013.00025
Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N et al (2008) Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 321(5887):421–422. https://doi.org/10.1126/science.1154433
Chen F, Guo M, Liu T, Jiang XL, Li JJ, Guo JC (2017) Magnetic resonance spectroscopy of brain circuits in patients with first-episode obsessive-compulsive disorder. Iran J Radiol 14(1):e13452. https://doi.org/10.5812/iranjradiol.15566
Choi C, Dimitrov IE, Douglas D, Patel A, Kaiser LG, Amezcua CA, Maher EA (2010) Improvement of resolution for brain coupled metabolites by optimized (1)H MRS at 7T. NMR Biomed 23(9):1044–1052. https://doi.org/10.1002/nbm.1529
Ciranna L (2006) Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol 4(2):101–114. https://doi.org/10.2174/157015906776359540
Cools R, Roberts AC, Robbins TW (2008) Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12(1):31–40. https://doi.org/10.1016/j.tics.2007.10.011
de Graaf RA, Rothman DL, Behar KL (2011) State of the art direct 13C and indirect 1H-[13C] NMR spectroscopy in vivo. A practical guide. NMR Biomed 24(8):958–972. https://doi.org/10.1002/nbm.1761
de Salles Andrade JB, Ferreira FM, Suo C, Yücel M, Frydman I, Monteiro M et al (2019) An MRI study of the metabolic and structural abnormalities in obsessive-compulsive disorder. Front Hum Neurosci 13:186–186. https://doi.org/10.3389/fnhum.2019.00186
de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM et al (2014) Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry 171(3):340–349. https://doi.org/10.1176/appi.ajp.2013.13040574
Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ et al (2013) Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. Eur Neuropsychopharmacol 23(11):1423–1431. https://doi.org/10.1016/j.euroneuro.2013.05.012
Dold M, Aigner M, Lanzenberger R, Kasper S (2015) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol 18(9):pyv047. https://doi.org/10.1093/ijnp/pyv047
Ebert D, Speck O, Konig A, Berger M, Hennig J, Hohagen F (1997) 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 74(3):173–176. https://doi.org/10.1016/s0925-4927(97)00016-4
Ebisu T, Rooney WD, Graham SH, Weiner MW, Maudsley AA (1994) N-Acetylaspartate as an in vivo marker of neuronal viability in Kainate-induced status Epilepticus: 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 14(3):373–382. https://doi.org/10.1038/jcbfm.1994.48
Eng GK, Sim K, Chen SH (2015) Meta-analytic investigations of structural grey matter, executive domain-related functional activations, and white matter diffusivity in obsessive compulsive disorder: an integrative review. Neurosci Biobehav Rev 52:233–257. https://doi.org/10.1016/j.neubiorev.2015.03.002
Fan S, Cath DC, van den Heuvel OA, van der Werf YD, Schöls C, Veltman DJ, Pouwels PJW (2017) Abnormalities in metabolite concentrations in tourette's disorder and obsessive-compulsive disorder-A proton magnetic resonance spectroscopy study. Psychoneuroendocrinology 77:211–217. https://doi.org/10.1016/j.psyneuen.2016.12.007
Figee M, de Koning P, Klaassen S, Vulink N, Mantione M, van den Munckhof P et al (2014) Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder. Biol Psychiatry 75(8):647–652. https://doi.org/10.1016/j.biopsych.2013.06.021
Fisher SK, Novak JE, Agranoff BW (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82(4):736–754. https://doi.org/10.1046/j.1471-4159.2002.01041.x
Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR (2000) Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 47(3):174–182. https://doi.org/10.1016/s0006-3223(99)00286-3
Gillan CM, Morein-Zamir S, Kaser M, Fineberg NA, Sule A, Sahakian BJ et al (2014) Counterfactual processing of economic action-outcome alternatives in obsessive-compulsive disorder: further evidence of impaired goal-directed behavior. Biol Psychiatry 75(8):639–646. https://doi.org/10.1016/j.biopsych.2013.01.018
Glover GH (2011) Overview of functional magnetic resonance imaging. Neurosurg Clin N Am 22(2):133–vii. https://doi.org/10.1016/j.nec.2010.11.001
Gnanavel S, Sharan P, Khandelwal S, Sharma U, Jagannathan NR (2014) Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder. MAGMA 27(5):407–417. https://doi.org/10.1007/s10334-013-0427-y
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989) The Yale-Brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry 46(11):1012–1016. https://doi.org/10.1001/archpsyc.1989.01810110054008
Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13(3):129–153. https://doi.org/10.1002/1099-1492(200005)13:3<129::Aid-nbm619>3.0.Co;2-v
Graat I, Figee M, Denys D (2017) Neurotransmitter dysregulation in OCD. In: Pittenger C (ed) Obsessive-compulsive disorder: phenomenology, pathophysiology, and treatment. Oxford University Press, Oxford, pp 271–288
Gruetter R (1993) Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29(6):804–811. https://doi.org/10.1002/mrm.1910290613
Haase A, Frahm J, Merboldt KD, Matthaei D, Hanicke W, Deimling M, Weber H (1986) Chemical-shift-selective (CHESS) FLASH MR imaging. Radiological Society of North America Inc
Haber SN, Behrens TE (2014) The neural network underlying incentive-based learning: implications for interpreting circuit disruptions in psychiatric disorders. Neuron 83(5):1019–1039. https://doi.org/10.1016/j.neuron.2014.08.031
Hardingham GE, Do KQ (2016) Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci 17(2):125–134. https://doi.org/10.1038/nrn.2015.19
Harrison BJ, Pujol J, Cardoner N, Deus J, Alonso P, López-Solà M et al (2013) Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 73(4):321–328. https://doi.org/10.1016/j.biopsych.2012.10.006
Hatchondo L, Jaafari N, Langbour N, Maillochaud S, Herpe G, Guillevin R, Guillevin C (2017) (1)H magnetic resonance spectroscopy suggests neural membrane alteration in specific regions involved in obsessive-compulsive disorder. Psychiatry Res Neuroimaging 269:48–53. https://doi.org/10.1016/j.pscychresns.2017.08.010
Hertz L, Zielke HR (2004) Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci 27(12):735–743. https://doi.org/10.1016/j.tins.2004.10.008
Hesse S, Stengler K, Regenthal R, Patt M, Becker G-A, Franke A et al (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive–compulsive disorder. Int J Neuropsychopharmacol 14(5):606–617. https://doi.org/10.1017/S1461145710001604
Honey GD, Suckling J, Zelaya F, Long C, Routledge C, Jackson S et al (2003) Dopaminergic drug effects on physiological connectivity in a human cortico-striato-thalamic system. Brain J Neurol 126(8):1767–1781. https://doi.org/10.1093/brain/awg184
Jackson SAW, Horst NK, Pears A, Robbins TW, Roberts AC (2016) Role of the perigenual anterior cingulate and orbitofrontal cortex in contingency learning in the marmoset. Cereb Cortex 26(7):3273–3284. https://doi.org/10.1093/cercor/bhw067
Jang JH, Kwon JS, Jang DP, Moon WJ, Lee JM, Ha TH et al (2006) A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am J Psychiatry 163(7):1202–1207. https://doi.org/10.1176/appi.ajp.163.7.1202
Juchem C, Nixon TW, Diduch P, Rothman DL, Starewicz P, de Graaf RA (2010) Dynamic shimming of the human brain at 7 tesla. Concepts Magn Reson Part B Magn Reson Eng 37B(3):116–128. https://doi.org/10.1002/cmr.b.20169
Juchem C, Nixon TW, McIntyre S, Boer VO, Rothman DL, de Graaf RA (2011) Dynamic multi-coil shimming of the human brain at 7 T. J Magnet Resonance 212(2):280–288. https://doi.org/10.1016/j.jmr.2011.07.005
Kehagia AA, Murray GK, Robbins TW (2010) Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20(2):199–204. https://doi.org/10.1016/j.conb.2010.01.007
Kitamura H, Shioiri T, Kimura T, Ohkubo M, Nakada T, Someya T (2006) Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-tesla. Acta Psychiatr Scand 114(2):101–108. https://doi.org/10.1111/j.1600-0447.2006.00858.x
Kong XZ, Boedhoe PSW, Abe Y, Alonso P, Ameis SH, Arnold PD et al (2019) Mapping cortical and subcortical asymmetry in obsessive-compulsive disorder: findings from the ENIGMA consortium. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2019.04.022
Krabbe S, Duda J, Schiemann J, Poetschke C, Schneider G, Kandel ER et al (2015) Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area. Proc Natl Acad Sci U S A 112(12):E1498–E1506. https://doi.org/10.1073/pnas.1500450112
Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, Lahti AC (2012) Neurometabolites in schizophrenia and bipolar disorder – a systematic review and meta-analysis. Psychiatry Res 203(2–3):111–125. https://doi.org/10.1016/j.pscychresns.2012.02.003
Krebs HA (1935) Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues. Biochem J 29(8):1951–1969. https://doi.org/10.1042/bj0291951
Lazaro L, Bargallo N, Andres S, Falcon C, Morer A, Junque C, Castro-Fornieles J (2012) Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment. Psychiatry Res 201(1):17–24. https://doi.org/10.1016/j.pscychresns.2011.01.017
Li Y, Zhang CC, Kathrin W, Zhang Y, He N, Jin H et al (2019) Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy. BMC Psychiatry 19(1):164. https://doi.org/10.1186/s12888-019-2160-1
Linden DE (2006) How psychotherapy changes the brain--the contribution of functional neuroimaging. Mol Psychiatry 11(6):528–538. https://doi.org/10.1038/sj.mp.4001816
Ljungberg M, Nilsson MKL, Melin K, Jönsson L, Carlsson A, Carlsson Å et al (2017) 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder. Acta Neuropsychiatr 29(3):179–190. https://doi.org/10.1017/neu.2016.52
Marsman A, van den Heuvel MP, Klomp DWJ, Kahn RS, Luijten PR, Hulshoff Pol HE (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull 39(1):120–129. https://doi.org/10.1093/schbul/sbr069
Mathews CA, Perez VB, Delucchi KL, Mathalon DH (2012) Error-related negativity in individuals with obsessive–compulsive symptoms: toward an understanding of hoarding behaviors. Biol Psychol 89(2):487–494. https://doi.org/10.1016/j.biopsycho.2011.12.018
Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y et al (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. NeuroImage 49(1):121–126. https://doi.org/10.1016/j.neuroimage.2009.07.069
McGovern RA, Sheth SA (2017) Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery. J Neurosurg 126(1):132–147. https://doi.org/10.3171/2016.1.Jns15601
Milad MR, Rauch SL (2012) Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 16(1):43–51. https://doi.org/10.1016/j.tics.2011.11.003
Miller BL (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4(2):47–52. https://doi.org/10.1002/nbm.1940040203
Mirza Y, O’Neill J, Smith EA, Russell A, Smith JM, Banerjee SP et al (2006) Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol 21(2):106–111. https://doi.org/10.1177/08830738060210020201
Moon C-M, Jeong G-W (2018) Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive–compulsive disorder. J Affect Disord 227:603–612. https://doi.org/10.1016/j.jad.2017.11.059
Morgiève M, N'Diaye K, Haynes WI, Granger B, Clair AH, Pelissolo A, Mallet L (2014) Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging. Psychol Med 44(7):1461–1473. https://doi.org/10.1017/s0033291713002237
Naaijen J, Zwiers MP, Amiri H, Williams SCR, Durston S, Oranje B et al (2017) Fronto-striatal glutamate in autism Spectrum disorder and obsessive compulsive disorder. Neuropsychopharmacology 42(12):2456–2465. https://doi.org/10.1038/npp.2016.260
Newberg AB, Moss AS, Monti DA, Alavi A (2011) Positron emission tomography in psychiatric disorders. Ann N Y Acad Sci 1228:E13–E25. https://doi.org/10.1111/j.1749-6632.2011.06162.x
Nixon TW, McIntyre S, Rothman DL, de Graaf RA (2008) Compensation of gradient-induced magnetic field perturbations. J Magn Reson 192(2):209–217. https://doi.org/10.1016/j.jmr.2008.02.016
Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H et al (1999) Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 92(2–3):83–91. https://doi.org/10.1016/s0925-4927(99)00040-2
Olatunji BO, Ferreira-Garcia R, Caseras X, Fullana MA, Wooderson S, Speckens A et al (2014) Predicting response to cognitive behavioral therapy in contamination-based obsessive-compulsive disorder from functional magnetic resonance imaging. Psychol Med 44(10):2125–2137. https://doi.org/10.1017/s0033291713002766
Olver JS, O'Keefe G, Jones GR, Burrows GD, Tochon-Danguy HJ, Ackermann U et al (2009) Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. J Affect Disord 114(1–3):321–326. https://doi.org/10.1016/j.jad.2008.06.020
O’Neill J, Piacentini JC, Chang S, Levitt JG, Rozenman M, Bergman L et al (2012) MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 36(1):161–168. https://doi.org/10.1016/j.pnpbp.2011.09.007
O’Neill J, Gorbis E, Feusner JD, Yip JC, Chang S, Maidment KM et al (2013) Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. J Psychiatr Res 47(4):494–504. https://doi.org/10.1016/j.jpsychires.2012.11.010
O’Neill J, Lai TM, Sheen C, Salgari GC, Ly R, Armstrong C et al (2016) Cingulate and thalamic metabolites in obsessive-compulsive disorder. Psychiatry Res Neuroimaging 254:34–40. https://doi.org/10.1016/j.pscychresns.2016.05.005
O’Neill J, Piacentini J, Chang S, Ly R, Lai TM, Armstrong CC et al (2017) Glutamate in pediatric obsessive-compulsive disorder and response to cognitive-behavioral therapy: randomized clinical trial. Neuropsychopharmacology 42(12):2414–2422. https://doi.org/10.1038/npp.2017.77
Ortiz AE, Ortiz AG, Falcon C, Morer A, Plana MT, Bargalló N, Lázaro L (2015) 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study. Eur Neuropsychopharmacol 25(1):60–68. https://doi.org/10.1016/j.euroneuro.2014.11.007
Park SE, Choi NG, Jeong GW (2017) Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy. Acta Neuropsychiatr 29(3):164–169. https://doi.org/10.1017/neu.2016.48
Parmar A, Sharan P, Khandelwal SK, Agarwal K, Sharma U, Jagannathan NR (2019) Brain neurochemistry in unmedicated obsessive–compulsive disorder patients and effects of 12-week escitalopram treatment: 1H-magnetic resonance spectroscopy study. Psychiatry Clin Neurosci 73(7):386–393. https://doi.org/10.1111/pcn.12850
Parnaudeau S, Taylor K, Bolkan SS, Ward RD, Balsam PD, Kellendonk C (2015) Mediodorsal thalamus hypofunction impairs flexible goal-directed behavior. Biol Psychiatry 77(5):445–453. https://doi.org/10.1016/j.biopsych.2014.03.020
Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A et al (2008) In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder. NeuroImage 42(1):306–314. https://doi.org/10.1016/j.neuroimage.2008.04.233
Pergola G, Danet L, Pitel AL, Carlesimo GA, Segobin S, Pariente J et al (2018) The regulatory role of the human Mediodorsal thalamus. Trends Cogn Sci 22(11):1011–1025. https://doi.org/10.1016/j.tics.2018.08.006
Pittenger C, Adams TG Jr, Gallezot J-D, Crowley MJ, Nabulsi N, James R et al (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87–96. https://doi.org/10.1016/j.jad.2016.02.021
Ramadan S, Lin A, Stanwell P (2013) Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed 26(12):1630–1646. https://doi.org/10.1002/nbm.3045
Reimold M, Smolka MN, Zimmer A, Batra A, Knobel A, Solbach C et al (2007) Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity – a [11C]DASB PET study. J Neural Transm 114(12):1603–1609. https://doi.org/10.1007/s00702-007-0785-6
Remijnse PL, Nielen MM, van Balkom AJ, Cath DC, van Oppen P, Uylings HB, Veltman DJ (2006) Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 63(11):1225–1236. https://doi.org/10.1001/archpsyc.63.11.1225
Robbins TW, Vaghi MM, Banca P (2019) Obsessive-compulsive disorder: puzzles and prospects. Neuron 102(1):27–47. https://doi.org/10.1016/j.neuron.2019.01.046
Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39(9):1096–1103. https://doi.org/10.1097/00004583-200009000-00008
Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ (2001) Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 16(9):636–641. https://doi.org/10.1177/088307380101600902
Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP et al (2004) Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 43(9):1146–1153. https://doi.org/10.1097/01.chi.0000132812.44664.2d
Rotge JY, Guehl D, Dilharreguy B, Tignol J, Bioulac B, Allard M et al (2009) Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 65(1):75–83. https://doi.org/10.1016/j.biopsych.2008.06.019
Rufer M, Fricke S, Moritz S, Kloss M, Hand I (2006) Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand 113(5):440–446. https://doi.org/10.1111/j.1600-0447.2005.00682.x
Rushworth MFS, Walton ME, Kennerley SW, Bannerman DM (2004) Action sets and decisions in the medial frontal cortex. Trends Cogn Sci 8(9):410–417. https://doi.org/10.1016/j.tics.2004.07.009
Sachdev PS, McBride R, Loo CK, Mitchell PB, Malhi GS, Croker VM (2001) Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry 62(12):981–984. https://doi.org/10.4088/jcp.v62n1211
Sachdev PS, Loo CK, Mitchell PB, McFarquhar TF, Malhi GS (2007) Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation. Psychol Med 37(11):1645–1649. https://doi.org/10.1017/s0033291707001092
Saxena S, Rauch SL (2000) Functional neuroimaging and the NEUROANATOMY of obsessive-compulsive disorder. Psychiatr Clin 23(3):563–586. https://doi.org/10.1016/S0193-953X(05)70181-7
Saxena S, Brody AL, Schwartz JM, Baxter LR (1998) Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry 35:26–37
Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S et al (1999) Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21(6):683–693. https://doi.org/10.1016/s0893-133x(99)00082-2
Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME (1996) Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53(2):109–113. https://doi.org/10.1001/archpsyc.1996.01830020023004
Shen J, Rothman DL, Hetherington HP, Pan JW (1999) Linear projection method for automatic slice shimming. Magn Reson Med 42(6):1082–1088. https://doi.org/10.1002/(sici)1522-2594(199912)42:6<1082::aid-mrm12>3.0.co;2-g
Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang D-R, Abi-Dargham A et al (2003) Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [11C]McN 5652. Biological Psychiatry 54(12):1414–1421. https://doi.org/10.1016/S0006-3223(03)00544-4
Simpson HB, Slifstein M, Bender J, Xu X, Hackett E, Maher MJ, Abi-Dargham A (2011) Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Biological Psychiatry 70(9):897–904. https://doi.org/10.1016/j.biopsych.2011.06.023
Simpson HB, Shungu DC, Bender J Jr, Mao X, Xu X, Slifstein M, Kegeles LS (2012) Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology 37(12):2684–2692. https://doi.org/10.1038/npp.2012.132
Simpson HB, Kegeles LS, Hunter L, Mao X, Van Meter P, Xu X et al (2015) Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy. Psychiatry Res 232(1):65–70. https://doi.org/10.1016/j.pscychresns.2015.01.009
Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J et al (2003) Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry 54(12):1399–1405. https://doi.org/10.1016/s0006-3223(03)00474-8
Soomro GM, Altman D, Rajagopal S, Oakley-Browne M (2008) Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008(1):CD001765–CD001765. https://doi.org/10.1002/14651858.CD001765.pub3
Sossi V (2018) Chapter one – advances in PET methodology. In: Politis M (ed) International review of neurobiology, vol 141. Academic Press, San Diego, pp 3–30
Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T et al (2008) A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. J Neural Transm (Vienna) 115(7):1051–1062. https://doi.org/10.1007/s00702-008-0045-4
Steen RG, Hamer RM, Lieberman JA (2005) Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30(11):1949–1962. https://doi.org/10.1038/sj.npp.1300850
Sumitani S, Harada M, Kubo H, Ohmori T (2007) Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res 154(1):85–92. https://doi.org/10.1016/j.pscychresns.2006.02.003
Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30(5):228–235. https://doi.org/10.1016/j.tins.2007.03.008
Tükel R, Aydın K, Ertekin E, Özyıldırım S, Taravari V (2014) Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate. Psychiatry Res 224(3):275–280. https://doi.org/10.1016/j.pscychresns.2014.08.012
Tükel R, Aydın K, Ertekin E, Özyıldırım S, Barburoğlu M (2015) 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites. Eur Arch Psychiatry Clin Neurosci 265(3):219–226. https://doi.org/10.1007/s00406-014-0545-1
Turner AJ (1986) Biochemistry and the central nervous system (fifth edition): by H. McIlwain and H S Bachelard. pp 660. Churchill Livingstone, Edinburgh. 1985. £40 ISBN 0-443-01961-4. Biochem Educ 14(1):46–46. https://doi.org/10.1016/0307-4412(86)90054-3
Vaghi MM, Hampshire A, Fineberg NA, Kaser M, Brühl AB, Sahakian BJ et al (2017) Hypoactivation and Dysconnectivity of a Frontostriatal circuit during goal-directed planning as an Endophenotype for obsessive-compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2(8):655–663. https://doi.org/10.1016/j.bpsc.2017.05.005
Vahabzadeh A, McDougle CJ (2014) Obsessive–compulsive disorder. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease. Academic Press, San Diego, pp 2512–2521
Wang R, Fan Q, Zhang Z, Chen Y, Zhu Y, Li Y (2018) Anterior thalamic radiation structural and metabolic changes in obsessive-compulsive disorder: a combined DTI-MRS study. Psychiatry Res Neuroimaging 277:39–44. https://doi.org/10.1016/j.pscychresns.2018.05.004
Weber AM, Soreni N, Stanley JA, Greco A, Mendlowitz S, Szatmari P et al (2014) Proton magnetic resonance spectroscopy of prefrontal white matter in psychotropic naïve children and adolescents with obsessive–compulsive disorder. Psychiatry Res Neuroimaging 222(1):67–74. https://doi.org/10.1016/j.pscychresns.2014.02.004
Whiteside SP, Port JD, Abramowitz JS (2004) A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 132(1):69–79. https://doi.org/10.1016/j.pscychresns.2004.07.001
Whiteside SP, Port JD, Deacon BJ, Abramowitz JS (2006) A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 146(2):137–147. https://doi.org/10.1016/j.pscychresns.2005.12.006
Whiteside SP, Abramowitz JS, Port JD (2012a) Decreased caudate N-acetyl-l-aspartic acid in pediatric obsessive-compulsive disorder and the effects of behavior therapy. Psychiatry Res 202(1):53–59. https://doi.org/10.1016/j.pscychresns.2011.11.010
Whiteside SP, Abramowitz JS, Port JD (2012b) The effect of behavior therapy on caudate N-acetyl-l-aspartic acid in adults with obsessive-compulsive disorder. Psychiatry Res 201(1):10–16. https://doi.org/10.1016/j.pscychresns.2011.04.004
Wong DF, Brasić JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y et al (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33(6):1239–1251. https://doi.org/10.1038/sj.npp.1301528
Wu K, Hanna GL, Rosenberg DR, Arnold PD (2012) The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 100(4):726–735. https://doi.org/10.1016/j.pbb.2011.10.007
Xin L, Tkáč I (2017) A practical guide to in vivo proton magnetic resonance spectroscopy at high magnetic fields. Anal Biochem 529:30–39. https://doi.org/10.1016/j.ab.2016.10.019
Yalçın O, Sener S, Konuş Boyunağa OL, Sarıpınar EG, Oğur T, Güney E et al (2011) Comparing brain magnetic resonance spectroscopy findings of pediatric treatment-naive obsessive-compulsive disorder patients with healthy controls. Turk Psikiyatri Derg 22(4):222–229
Yang S, Hu J, Kou Z, Yang Y (2008) Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4T. Magn Reson Med 59(2):236–244. https://doi.org/10.1002/mrm.21463
Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J et al (2007) Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry 64(8):946–955. https://doi.org/10.1001/archpsyc.64.8.946
Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J et al (2008) Anterior cingulate glutamate–glutamine levels predict symptom severity in women with obsessive–compulsive disorder. Aust N Z J Psychiatry 42(6):467–477. https://doi.org/10.1080/00048670802050546
Zhang Z, Fan Q, Bai Y, Wang Z, Zhang H, Xiao Z (2016) Brain gamma-Aminobutyric acid (GABA) concentration of the prefrontal lobe in Unmedicated patients with obsessive-compulsive disorder: a research of magnetic resonance spectroscopy. Shanghai Arch Psychiatry 28(5):263–270. https://doi.org/10.11919/j.issn.1002-0829.216043
Zheng H, Yang W, Zhang B, Hua G, Wang S, Jia F et al (2020) Reduced anterior cingulate glutamate of comorbid skin-picking disorder in adults with obsessive-compulsive disorder. J Affect Disord 265:193–199. https://doi.org/10.1016/j.jad.2020.01.059
Zhu Y, Fan Q, Han X, Zhang H, Chen J, Wang Z et al (2015) Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy. J Affect Disord 178:193–200. https://doi.org/10.1016/j.jad.2015.03.008
Zurowski B, Kordon A, Weber-Fahr W, Voderholzer U, Kuelz AK, Freyer T et al (2012) Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 262(7):617–624. https://doi.org/10.1007/s00406-012-0304-0
Acknowledgements
MB was supported by her studentship from the Mental Health Research UK. LCM has received support from the Swiss National Science Foundation: Doc-mobility grant No. P1GEP3_191308. PB was supported by the Sir Henry Wellcome Trust Postdoctoral Research Fellowship (204727/Z/16/Z).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Biria, M., Cantonas, LM., Banca, P. (2021). Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder. In: Fineberg, N.A., Robbins, T.W. (eds) The Neurobiology and Treatment of OCD: Accelerating Progress. Current Topics in Behavioral Neurosciences, vol 49. Springer, Cham. https://doi.org/10.1007/7854_2020_201
Download citation
DOI: https://doi.org/10.1007/7854_2020_201
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75392-4
Online ISBN: 978-3-030-75393-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)